End Cash (Quarterly)

End Cash: The amount of cash held by the company for the given period.

Cardinal Health, Inc. (CAH) had End Cash of $3.33B for the most recently reported fiscal quarter, ending 2025-03-31.

Quarterly Annual

Figures for fiscal quarter ending 2025-03-31

Income Statement Financials
Revenue	$54.88B
Net Income	$506.00M
Cost of Goods Sold	$52.76B
Gross Profit	$2.12B
Operating Expenses	$54.15B
Operating Income	$730.00M
Non-Operating Income/Expense	$-65.00M
Pre-Tax Income	$665.00M
Normalized Pre-Tax Income	$665.00M
Income after Taxes	$508.00M
Income from Continuous Operations	$508.00M
Consolidated Net Income/Loss	$508.00M
Normalized Income after Taxes	$508.00M
EBIT	$730.00M
EBITDA	$937.00M
Weighted-Average Shares Outstanding (Basic)	240.00M
Weighted-Average Shares Outstanding (Diluted)	241.00M
Earnings per Share (EPS) (Basic)	$2.11
Earnings per Share (EPS) (Diluted)	$2.10
Balance Sheet Financials
Current Assets	$34.59B
Property, Plant, and Equipment	$2.66B
Long-Term Assets	$15.28B
Total Assets	$49.87B
Current Liabilities	$36.66B
Long-Term Debt	$7.14B
Long-Term Liabilities	$15.11B
Total Liabilities	$51.77B
Common Equity	$-1.90B
Tangible Shareholders Equity	$-12.91B
Shareholders Equity	$-1.90B
Common Shares Outstanding	239.00M
Cash Flow Statement Financials
Cash Flow from Operating Activities	$870.00M
Cash Flow from Investing Activities	$-3.96B
Cash Flow from Financial Activities	$1.28B
Beginning Cash	$5.13B
End Cash	$3.33B
Increase/Decrease in Cash	$-1.81B
Stock-Based Compensation	$91.00M
Common Stock Dividends Paid	$-374.00M
Preferred Stock Dividends Paid	--
Fundamental Metrics & Ratios
Current Ratio	0.94
Non-Performing Assets / Total Loans	--
Loan Loss Reserves / Non-Performing Loans	--
Debt to Capital Ratio	1.36
Debt to Equity Ratio	-4.05
Gross Margin	3.87%
Operating Margin	1.33%
EBIT Margin	1.33%
EBITDA Margin	--
Pre-Tax Profit Margin	1.21%
Profit Margin	0.92%
Free Cash Flow	$558.00M
Loss Ratio	--
Expense Ratio	--
Combined Ratio	--
Asset Turnover	1.10
Inventory Turnover	3.26
Receiveable Turnover	4.33
Days Sales in Receivables	20.77
Return on Equity	-26.77%
Return on Tangible Equity	-3.93%
Return on Assets	1.02%
Return on Investments	9.70%
Book Value Per Share	$-7.94
Free Cash Flow per Share	$2.32
Operating Cash Flow per Share	$3.61

Data from Zacks Investment Research, Inc.